The present CD8+ T-lymphocytes progressively kill MHC-I-positive cells, leaving the MHC-I-negative ones behind, rendering it impossible to attract new CD8+ T-lymphocytes (‘cold tumour’) [14,35]. This evidence concerns the gene CD8A and neoplasm.